Grifols cuts institutional tranche after flood of bank demand
Spanish healthcare group Grifols is meeting investors this week to discuss a $3.4bn loan backing its $4.5bn takeover of US firm Talecris after amending the deal on the back of strong demand from banks.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article:
- ✔ 4,000 annual insights
- ✔ 700+ notes and long-form analyses
- ✔ European securitization issuance database
- ✔ Daily newsletters across markets and asset classes
- ✔ 1 weekly securitization podcast
